Forgione, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 1.657
AS - Asia 1.373
EU - Europa 1.348
SA - Sud America 241
Continente sconosciuto - Info sul continente non disponibili 49
AF - Africa 36
OC - Oceania 2
Totale 4.706
Nazione #
US - Stati Uniti d'America 1.602
SG - Singapore 612
DE - Germania 561
CN - Cina 386
BR - Brasile 197
SE - Svezia 195
FR - Francia 128
VN - Vietnam 93
UA - Ucraina 89
IE - Irlanda 76
IT - Italia 74
GB - Regno Unito 64
JP - Giappone 48
FI - Finlandia 46
ID - Indonesia 42
IN - India 37
TR - Turchia 36
RU - Federazione Russa 29
AR - Argentina 28
BD - Bangladesh 25
CA - Canada 20
PL - Polonia 20
KR - Corea 19
HK - Hong Kong 17
BE - Belgio 16
MX - Messico 12
IQ - Iraq 11
NL - Olanda 11
ZA - Sudafrica 10
CH - Svizzera 8
IR - Iran 8
AT - Austria 7
PK - Pakistan 6
EC - Ecuador 5
JM - Giamaica 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EG - Egitto 4
ES - Italia 4
MA - Marocco 4
PH - Filippine 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CO - Colombia 3
DO - Repubblica Dominicana 3
EU - Europa 3
IL - Israele 3
KE - Kenya 3
MD - Moldavia 3
TN - Tunisia 3
BS - Bahamas 2
BZ - Belize 2
CI - Costa d'Avorio 2
CL - Cile 2
GE - Georgia 2
HR - Croazia 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
RE - Reunion 2
SV - El Salvador 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.660
Città #
Singapore 316
Ashburn 190
Chandler 181
San Jose 156
Dublin 76
Hefei 71
Chicago 65
Beijing 59
Jacksonville 51
Tukwila 48
Los Angeles 47
San Mateo 47
Tokyo 47
Lauterbourg 45
Jakarta 41
Ann Arbor 40
Marseille 39
Nanjing 38
Ho Chi Minh City 34
Nürnberg 34
New York 33
Munich 30
Frankfurt am Main 28
Milan 28
Helsinki 25
Izmir 25
Hanoi 22
Boston 21
Dallas 21
Woodbridge 21
Kent 19
Moscow 19
Wilmington 19
Dearborn 18
Seoul 18
Houston 17
Princeton 17
Brussels 15
Boardman 14
Hong Kong 14
Kraków 13
Santa Clara 13
Phoenix 12
São Paulo 12
Düsseldorf 10
Shanghai 10
Bremen 9
Nanchang 9
Nuremberg 9
Shenyang 9
Brasília 8
Redwood City 8
The Dalles 8
Buffalo 7
Manaus 7
Orem 7
Poplar 7
Provo 7
Toronto 7
Zhengzhou 7
Brooklyn 6
Cape Town 6
Fremont 6
Paris 6
Rome 6
San Francisco 6
Utrecht 6
Zurich 6
Baghdad 5
Denver 5
Jiaxing 5
Jinan 5
Kunming 5
Las Vegas 5
Leawood 5
Pune 5
Stockholm 5
Tabriz 5
Warsaw 5
Ankara 4
Atlanta 4
Boydton 4
Charlotte 4
Guangzhou 4
Guarulhos 4
Hangzhou 4
Hebei 4
Miami 4
Montreal 4
Salvador 4
Tianjin 4
Turku 4
Vienna 4
Baku 3
Bexley 3
Brno 3
Buenos Aires 3
Cattolica 3
Changsha 3
Chennai 3
Totale 2.408
Nome #
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 252
-Hepatic steatosis and vascular disease 240
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 219
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 202
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 199
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 177
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 177
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 173
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 172
-Fatty liver and drugs 164
gastroesophageal reflux disease: facts and uncertaines 155
Tromboembolism and breast cancer: the hidden risk for patient and physician 147
-Nonalcoholic fatty liver disease: defining a common problem 141
Alcoholic and nonalcoholic forms of fatty liver disease. 133
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. 122
Pattern of macrovascular invasion in hepatocellular carcinoma 121
Monofocal hepatocellular carcinoma: How much does size matter? 103
anticholinergic syndrome due to " Devil's herb': when risks come from the ancient time 102
-The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. 101
PREVALENCE OF LIVER STEATOSIS AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 97
Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. 91
Genetic and environmental factors responsible for oxidative stress in now alcoholic fatty liver disease (NAFLD) 88
Anticholinergic syndrome due to 'Devil's herb': when risks come from the ancient time 87
Body composition and nutrient utilisation in patients with non-alcoholic steato-hepatitis (NASH) 86
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 81
Use of G-CSF during acute on chronic liver failure: Clinical and biochemical safety profile 81
Mild hepatitis at recommended doses of acetaminophen in patients with evidence of constitutionally enhanced cytochrome P450 system activity 80
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 79
PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 79
Intestinal permeability in nonalcoholic fatty liver disease (NAFLD) 77
CXCR4, vegfr and VLA-4 levels in peripheral blood lymphocytes of patients with acute on chronic liver failure treated with G-CSF 72
G) Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test 70
Thromboembolism and breast cancer: the hidden risk for patient and physician 69
Eighteen needles to forget...an unnamed past 66
Fibrogenesis and fibrosis in nonalcoholic steatohepatitis 64
Serum levels of metalloproteinases and their inhibitors in nonalcoholic steatohepatitis 62
FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 61
Quantitative liver function tests to assess MEHOS activity in NASH patients 60
C-Methacetin breath test in patients with nonalcoholic steatohepatitis after hypocaloric diet therapy 58
Serum markers of fibrogenesis and fibrosis in nonalcoholic steatohepatitis (NASH) 51
Nonalcoholic-Steatohepatitis (NASH) and hepatic mitochondrial beta-oxidation 47
Totale 4.706
Categoria #
all - tutte 20.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022195 0 29 6 23 11 4 2 35 3 14 32 36
2022/2023629 53 65 30 81 58 80 53 43 73 51 32 10
2023/2024329 25 118 4 15 28 31 11 4 0 24 36 33
2024/2025710 11 17 66 8 65 23 17 41 107 59 165 131
2025/20261.681 281 71 111 167 281 83 247 82 113 114 73 58
2026/2027101 62 39 0 0 0 0 0 0 0 0 0 0
Totale 4.706